Aralez Bio

Private

San Leandro, CaliforniaHealthcare & Life Scienceshttps://www.aralezbio.com/

Last Round

Series A

Oct 29, 2024

Total Funding Raised

$32.6M

Company Overview

Aralez Bio is a biotechnology company that develops and manufactures noncanonical amino acids using a proprietary enzymatic platform for pharmaceutical, agricultural, and cosmetic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

biocatalysisnon-canonical amino acidsncAAenzyme engineeringsynthetic biologysynbiopeptide therapeuticsdrug discoverycustom synthesischiral building blocksgreen chemistrysustainable manufacturingbiomanufacturingcomputational protein designcontract research organizationCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aralez Bio Comps

Public and private peers based on sector, stage, and business model.

Aralez Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aralez Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Oct 29, 2024
Grant	Oct 3, 2024
Seed	Aug 22, 2022
Accelerator	May 22, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Tina Boville

Co-founder & CEO

Founding Team

Aralez Bio Investors

Notable investors and investment history

Aralez Bio investors
Investor	Rounds
Impact Science	Series A
Spero Ventures	Series A
Good Growth Capital	Seed, Series A
U.S. Department of Health and Human Services	Grant
Cyclotron Road	Accelerator
Climate Capital	Seed
Impact Science Ventures	Series A

View all Investors

Aralez Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Aralez Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aralez Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Leandro, California

Employee Range36

Year Founded2019

Last FundingOct 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.